Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients

American Journal of Transplantation

Volumn 16, Issue 7, 2016, Pages 1999-2015

  Ezzelarab, M B ^a   Zhang, H ^a   Guo, H ^a   Lu, L ^a   Zahorchak, A F ^a   Wiseman, R W ^b   Nalesnik, M A ^c   Bhama, J K ^c   Cooper, D K C ^a,c   Thomson, A W ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

animal models: nonhuman primate; basic (laboratory) research science; heart transplantation cardiology; immune regulation; immunobiology; lymphocyte biology; T cell biology; translational research science

Indexed keywords

ALLOANTIBODY; GAMMA INTERFERON; INTERLEUKIN 6 RECEPTOR; MONOCLONAL ANTIBODY; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EX VIVO STUDY; GRAFT RECIPIENT; HEART TRANSPLANTATION; IMMUNOCOMPETENT CELL; MACACA FASCICULARIS; MAINTENANCE THERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY T LYMPHOCYTE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

EID: 84976493200     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13685     Document Type: Article

References (75)

1. Bluestone JA, Thomson AW, Shevach EM, Weiner HL. What does the future hold for cell-based tolerogenic therapy? Nat Rev Immunol 2007; 7: 650–654.
2. Wood KJ, Bushell A, Hester J. Regulatory immune cells in transplantation. Nat Rev Immunol 2012; 12: 417–430.
3. Issa F, Hester J, Goto R, Nadig SN, Goodacre TE, Wood K. Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model. Transplantation 2010; 90: 1321–1327.
4. Juvet SC, Whatcott AG, Bushell AR, Wood KJ. Harnessing regulatory T cells for clinical use in transplantation: The end of the beginning. Am J Transplant 2014; 14: 750–763.
5. Brunstein CG, Miller JS, Cao Q, et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 2011; 117: 1061–1070.
6. Hutchinson JA, Geissler EK. Now or never? The case for cell-based immunosuppression in kidney transplantation. Kidney Int 2015; 87: 1116–1124.
7. McDonald-Hyman C, Turka LA, Blazar BR. Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Sci Transl Med 2015; 7: 280rv282.
8. MacDonald KG, Orban PC, Levings MK. T regulatory cell therapy in transplantation: Stability, localization and functional specialization. Curr Opin Organ Transplant 2012; 17: 343–348.
9. Burrell BE, Nakayama Y, Xu J, Brinkman CC, Bromberg JS. Regulatory T cell induction, migration, and function in transplantation. J Immunol 2012; 189: 4705–4711.
10. Braza F, Durand M, Degauque N, Brouard S. Regulatory T Cells in Kidney Transplantation: New Directions? Am J Transplant 2015; 15: 2288–2300.
11. Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunol Rev 2014; 259: 173–191.
12. Tang Q. Pharmacokinetics of therapeutic Tregs. Am J Transplant 2014; 14: 2679–2680.
13. Trzonkowski P, Bacchetta R, Battaglia M, et al. Hurdles in therapy with regulatory T cells. Sci Transl Med 2015; 7: 304 ps318.
14. Bailey-Bucktrout SL, Martinez-Llordella M, Zhou X, et al. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 2013; 39: 949–962.
15. Zhou X, Bailey-Bucktrout SL, Jeker LT, et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009; 10: 1000–1007.
16. Degauque N, Mariat C, Kenny J, et al. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 2008; 118: 735–741.
17. Yurchenko E, Shio MT, Huang TC, et al. Inflammation-driven reprogramming of CD4 + Foxp3 + regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE 2012; 7: e35572.
18. Ueno A, Jijon H, Chan R, et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4 + T cells and defective suppressive function of circulating Foxp3 + regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 2522–2534.
19. d'Hennezel E, Piccirillo CA. Functional plasticity in human FOXP3(+) regulatory T cells: Implications for cell-based immunotherapy. Hum Vaccin Immunother 2012; 8: 1001–1005.
20. Yeh H, Moore DJ, Markmann JF, Kim JI. Mechanisms of regulatory T cell counter-regulation by innate immunity. Transplant Rev (Orlando) 2013; 27: 61–64.
21. Koehn BH, Apostolova P, Haverkamp JM, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood 2015; 126: 1621–1628.
22. Afzali B, Mitchell PJ, Scotta C, et al. Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells. Am J Transplant 2011; 11: 1734–1742.
23. Nadazdin O, Boskovic S, Murakami T, et al. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates. Sci Transl Med 2011; 3: 86ra51.
24. Kean LS, Gangappa S, Pearson TC, Larsen CP. Transplant tolerance in non-human primates: Progress, current challenges and unmet needs. Am J Transplant 2006; 6: 884–893.
25. Torrealba JR, Katayama M, Fechner JH Jr, et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1 + CD4 + T regulatory cell infiltrates. J Immunol 2004; 172: 5753–5764.
26. Bashuda H, Kimikawa M, Seino K, et al. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest 2005; 115: 1896–1902.
27. Ma A, Qi S, Song L, et al. Adoptive transfer of CD4 + CD25 + regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys. Int Immunopharmacol 2011; 11: 618–629.
28. Anderson A, Martens CL, Hendrix R, et al. Expanded nonhuman primate Tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. Am J Transplant 2008; 8: 2252–2264.
29. Dons EM, Raimondi G, Zhang H, et al. Ex vivo-expanded cynomolgus macaque regulatory T cells are resistant to alemtuzumab-mediated cytotoxicity. Am J Transplant 2013; 13: 2169–2178.
30. Dons EM, Raimondi G, Cooper DK, Thomson AW. Non-human primate regulatory T cells: Current biology and implications for transplantation. Transplantation 2010; 90: 811–816.
31. Singh K, Kozyr N, Stempora L, et al. Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus. Am J Transplant 2012; 12: 1441–1457.
32. Singh K, Stempora L, Harvey RD, et al. Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant 2014; 14: 2691–2703.
33. Zhang H, Guo H, Lu L, et al. Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates. Am J Transplant 2015; 15: 1253–1266.
34. Feng X, Kajigaya S, Solomou EE, et al. Rabbit ATG but not horse ATG promotes expansion of functional CD4 + CD25highFOXP3 + regulatory T cells in vitro. Blood 2008; 111: 3675–3683.
35. Boenisch O, Lopez M, Elyaman W, Magee CN, Ahmad U, Najafian N. Ex vivo expansion of human Tregs by rabbit ATG is dependent on intact STAT3-signaling in CD4(+) T cells and requires the presence of monocytes. Am J Transplant 2012; 12: 856–866.
36. Basu S, Golovina T, Mikheeva T, June CH, Riley JL. Cutting edge: Foxp3-mediated induction of pim 2 allows human T regulatory cells to preferentially expand in rapamycin. J Immunol 2008; 180: 5794–5798.
37. Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4 + CD25 + FOXP3 + regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006; 177: 8338–8347.
38. Kabelitz D, Wesch D, Oberg HH. Regulation of regulatory T cells: Role of dendritic cells and toll-like receptors. Crit Rev Immunol 2006; 26: 291–306.
39. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science 2003; 299: 1033–1036.
40. Komatsu N, Okamoto K, Sawa S, et al. Pathogenic conversion of Foxp3 + T cells into TH17 cells in autoimmune arthritis. Nat Med 2014; 20: 62–68.
41. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol 2006; 176: 4632–4639.
42. Zwang NA, Turka LA. Homeostatic expansion as a barrier to lymphocyte depletion strategies. Curr Opin Organ Transplant 2014; 19: 357–362.
43. Wiseman RW, Karl JA, Bohn PS, Nimityongskul FA, Starrett GJ, O'Connor DH. Haplessly hoping: Macaque major histocompatibility complex made easy. ILAR J 2013; 54: 196–210.
44. Cooper DKC, Ye Y, Niekrasz M. Heart transplantation in primates. In: Cramer DV, Podesta LG, Makowka L, editors. Handbook of animal models in transplantation research. Boca Raton, FL: CRC Press, Inc., 1994; p. 173–200.
45. Stalder M, Tye T, Lam TT, et al. Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts. J Heart Lung Transplant 2005; 24: 215–221.
46. Kwun J, Oh BC, Gibby AC, et al. Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. Am J Transplant 2012; 12: 2641–2651.
47. Guo H, Zhang H, Lu L, Ezzelarab MB, Thomson AW. Generation, cryopreservation, function and in vivo persistence of ex vivo expanded cynomolgus monkey regulatory T cells. Cell Immunol 2015; 295: 19–28.
48. Himmel ME, MacDonald KG, Garcia RV, Steiner TS, Levings MK. Helios+ and Helios- cells coexist within the natural FOXP3 + T regulatory cell subset in humans. J Immunol 2013; 190: 2001–2008.
49. Huehn J, Polansky JK, Hamann A. Epigenetic control of FOXP3 expression: The key to a stable regulatory T-cell lineage? Nat Rev Immunol 2009; 9: 83–89.
50. Marco MR, Dons EM, van der Windt DJ, et al. Post-transplant repopulation of naive and memory T cells in blood and lymphoid tissue after alemtuzumab-mediated depletion in heart-transplanted cynomolgus monkeys. Transpl Immunol 2013; 29: 88–98.
51. Kelishadi SS, Azimzadeh AM, Zhang T, et al. Preemptive CD20 + B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest 2010; 120: 1275–1284.
52. Azimzadeh AM, Pfeiffer S, Wu G, et al. Alloimmunity in primate heart recipients with CD154 blockade: Evidence for alternative costimulation mechanisms. Transplantation 2006; 81: 255–264.
53. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587–593.
54. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005; 24: 1710–1720.
55. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789–3796.
56. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4 + CD25 + regulatory T cells promote experimental transplantation tolerance. Blood 2007; 109: 827–835.
57. Xia G, He J, Leventhal JR. Ex vivo-expanded natural CD4 + CD25 + regulatory T cells synergize with host T-cell depletion to promote long-term survival of allografts. Am J Transplant 2008; 8: 298–306.
58. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4 + CD25 + Foxp3 + regulatory T lymphocytes. Nat Med 2008; 14: 88–92.
59. Zheng SG, Meng L, Wang JH, et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4 + CD25 + cells in the recipient. Int Immunol 2006; 18: 279–289.
60. Gurkan S, Luan Y, Dhillon N, et al. Immune reconstitution following rabbit antithymocyte globulin. Am J Transplant 2010; 10: 2132–2141.
61. Valdez-Ortiz R, Bestard O, Llaudo I, et al. Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation. Transpl Int 2015; 28: 108–119.
62. Nadazdin O, Boskovic S, Murakami T, et al. Phenotype, distribution and alloreactive properties of memory T cells from cynomolgus monkeys. Am J Transplant 2010; 10: 1375–1384.
63. Pearl JP, Parris J, Hale DA, et al. Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion. Am J Transplant 2005; 5: 465–474.
64. Koyama I, Nadazdin O, Boskovic S, et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007; 7: 1055–1061.
65. Yang J, Brook MO, Carvalho-Gaspar M, et al. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci U S A 2007; 104: 19954–19959.
66. Lee M, Moore DJ, Jarrett BP, et al. Promotion of allograft survival by CD4 + CD25 + regulatory T cells: Evidence for in vivo inhibition of effector cell proliferation. J Immunol 2004; 172: 6539–6544.
67. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641–1646.
68. Preville X, Flacher M, LeMauff B, et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460–468.
69. Tang Q, Lee K. Regulatory T-cell therapy for transplantation: How many cells do we need? Curr Opin Organ Transplant 2012; 17: 349–354.
70. Putnam AL, Safinia N, Medvec A, et al. Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant 2013; 13: 3010–3020.
71. Vu MD, Xiao X, Gao W, et al. OX40 costimulation turns off Foxp3 + Tregs. Blood 2007; 110: 2501–2510.
72. Last'ovicka J, Budinsky V, Spisek R, Bartunkova J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell Immunol 2009; 256: 79–85.
73. Duarte JH, Zelenay S, Bergman ML, Martins AC, Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009; 39: 948–955.
74. Bloom D, Chang Z, Pauly K, et al. BAFF is increased in renal transplant patients following treatment with alemtuzumab. Am J Transplant 2009; 9: 1835–1845.
75. Donckier V, Craciun L, Miqueu P, et al. Expansion of memory-type CD8 + T cells correlates with the failure of early immunosuppression withdrawal after cadaver liver transplantation using high-dose ATG induction and rapamycin. Transplantation 2013; 96: 306–315.